Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-19
2007-06-19
Wilson, James O. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S256000, C514S252010, C514S314000, C514S399000, C514S311000, C514S357000, C544S160000, C544S400000, C546S169000, C546S192000, C546S257000, C546S263000, C548S314700, C548S556000, C548S567000, C548S309400, C564S085000, C564S098000
Reexamination Certificate
active
11235524
ABSTRACT:
α- and β-amino acid hydroxyethylamino sulfonyl urea derivative compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
REFERENCES:
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Freidinger
patent: H725 (1990-01-01), Gordon
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5578606 (1996-11-01), Vazquez et al.
patent: 6022872 (2000-02-01), Vazquez et al.
patent: 6211176 (2001-04-01), Vazquez et al.
patent: 6403585 (2002-06-01), Vazquez et al.
patent: 6683648 (2004-01-01), Vazquez et al.
patent: 2004/0171653 (2004-09-01), Vazquez et al.
patent: A-79823/87 (1988-04-01), None
patent: 114993 (1984-08-01), None
patent: 172347 (1986-02-01), None
patent: 223437 (1987-05-01), None
patent: 0 264 795 (1988-04-01), None
patent: 337714 (1989-10-01), None
patent: 0 342541 (1989-11-01), None
patent: 0 346 847 (1989-12-01), None
patent: 356223 (1990-02-01), None
patent: 389898 (1990-10-01), None
patent: 389898 (1990-10-01), None
patent: 393445 (1990-10-01), None
patent: 393457 (1990-10-01), None
patent: 402646 (1990-12-01), None
patent: 104041 (1993-10-01), None
patent: 2184730 (1987-07-01), None
patent: 2200115 (1988-07-01), None
patent: 2209752 (1989-05-01), None
patent: WO84/03044 (1984-08-01), None
patent: WO 92/00750 (1992-01-01), None
Roberts et al, “Rational Design of Peptide-based Proteinase Inhibitors,” Science, 248, 358 (1990).
Erickson et al, “Design Activity, and 2.8Å Crystal Structure of a C2Symmetric Inhibitor Complexed to HIV-1 Protease,” Science, 249, 527 (1990).
Pearl et al, “Sequence specificity of retroviral proteases” Nature, 328, p. 482 (1987).
Martin, Drugs of the Future, 16(3), 210-212 (1991).
Meek et al,Letter To Nature, 343, 90-92 (1990).
McQuade et al,Science, 274, 454-456 (1990).
Rich et al, Peptide Inhibitors of Proteases, 511-520.
Rosenberg et al,J. Med. Chem., 30, 1224-1228 (1987).
DeCrescenzo Gary A.
Getman Daniel P.
Mueller Richard A.
Sun Eric T.
Talley John J.
Banner & Witcoff Ltd
G.D. Searle & Co.
Monsanto Company
Sackey Ebenezer
Wilson James O.
LandOfFree
α- and β-amino acid hydroxyethlamino sulfonyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α- and β-amino acid hydroxyethlamino sulfonyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α- and β-amino acid hydroxyethlamino sulfonyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839788